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Differential effects of local application of BMP-2 or TGF-b1 on both
articular cartilage composition and osteophyte formation
By Henk M. van Beuningen, Harrie L. Glansbeek, Peter M. van der Kraan and Wim B. van den Berg
Department of Rheumatology, University Hospital Nijmegen, The Netherlands
Summary
Objective: The related molecules bone morphogenetic protein-2 (BMP-2) and transforming growth factor
beta-1 (TGF-b1) have both been shown to stimulate chondrocyte proteoglycan (PG) synthesis in vitro.
We investigated the in-vivo effects of these factors on articular cartilage PG metabolism.
Design: Several doses of BMP-2 or TGF-b1 were injected into the murine knee joint, once or repeatedly.
Patellar cartilage PG synthesis was measured by [35S]-sulfate incorporation and reverse transcriptase
polymerase chain reaction (RT-PCR). PG content was analyzed by measuring safranin O staining
intensity on histologic sections.
Results: A single injection of 200 ng BMP-2 induced a much earlier and more impressive stimulation
of articular cartilage PG synthesis, than 200 ng TGF-b1. RT-PCR revealed that both factors upregulated
mRNA of aggrecan more than that of biglycan and decorin. However, 21 days after a single injection
of 200 ng TGF-b1 PG synthesis still was significantly increased, while stimulation by BMP-2 only lasted
for 3 to 4 days. Stimulation by BMP-2 could be prolonged to at least 2 weeks by triple injections of 200 ng
each, at alternate days. Remarkably, even after this intense exposure to BMP-2, stimulation of PG
synthesis was not reflected in long-lasting enhancement of PG content of articular cartilage. In contrast,
even a single injection with 200 ng of TGF-b1 induced prolonged enhancement of PG content. After
repeated injections, both BMP-2 and TGF-b1 induced chondrogenesis at specific sites. ‘Chondrophytes’
induced by BMP-2 were found predominantly in the region where the growth plates meet the joint space,
while those triggered by TGF-b1 originated from the periosteum also at sites remote from the growth
plates.
Conclusions: BMP-2 and TGF-b stimulate PG synthesis and PG content with different kinetics, and
these factors have different chondro-inductive properties.
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Introduction
Loss of proteoglycans (PGs) from articular
cartilage is a feature of several joint diseases.
Depletion of these highly sulfated and hydrated
molecules decreases the resistance of cartilage to
mechanical forces and to extended enzymatic
degradation and could therefore be the first step in
cartilage degeneration. Factors that are able to
stimulate PG synthesis and to accelerate replenish-
ment of PGs in depleted cartilage could be of
significant therapeutic value. Transforming
growth factor beta-1 (TGF-b1) and bone morpho-
genetic protein-2 (BMP-2) have been shown to
stimulate chondrocyte PG synthesis in vitro [1–5].
Therefore, they are possible candidates in the
search for factors that improve restoration of
articular cartilage. TGF-bs and BMPs belong to
the TGF-b superfamily [6, 7] This superfamily
consists of dimeric molecules of which each
monomer contains at least seven conserved
cysteine residues [8]. The proteins signal by
serine/threonine kinases [6, 9]. In earlier studies
[10] we showed that intra-articular injection of
200 ng TGF-b1 into the knee joint of C57Bl/6 mice
induces long-lasting stimulation of patellar carti-
lage PG synthesis. However, we also found that
multiple injection induces fibrosis (thickening of
synovium and ligaments) and formation of ‘chon-
drophytes’, originating from the periosteum, and
developing into osteophytes. In the present study
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we tried to identify dose regimens which might
preserve the anabolic effect on cartilage without
pronounced side effects on synovial tissue and
periosteal tissue. Moreover, we made a comparison
with BMP-2. The latter factor belongs to the BMP
family and has been shown to possess strong
chondrocyte PG synthesis stimulatory activity, in
vitro [4, 5], whereas information on in-vivo effects
on cartilage metabolism is lacking. It was found
that both factors stimulate chondrocyte PG
synthesis, but with markedly different kinetic
profiles. Moreover, both factors induced chondro-
cytes, but at different, characteristic, regions of
the joint.
Materials and Methods
animals
Male C57Bl/6 mice aged 12 weeks were used.
They were fed a standard diet and tap water
adlibitum.
growth factors
Recombinant human BMP-2, rhTGF-b1, and
rhTGF-b2 were kindly provided by Genetics
Institute Inc (Cambridge, MA, U.S.A.), Genentech
Inc (San Francisco, CA, U.S.A.), and Novartis
(Basel, Switzerland), respectively.
intra-articular injections
BMP-2 and TGF-bs were dissolved in
saline + 0.1% ultrapure bovine serum albumin
(Sigma, St Louis, MO, USA). Six microliter
volumes were injected into the joint cavity of the
right knee. BMP-2 and TFG-b were administered in
2, 20, 200, or 400 ng dosi. Simultaneously, the
contralateral joint received an equal volume of
vehicle (saline + 0.1% bovine serum albumin).
Each joint was injected once or three times at
alternate days.
histology
Whole knee joints were dissected and processed
as previously described [11]. Semiserial frontal
sections were stained by hematoxylin/eosin or
safranin O/fast green for examination of cells and
cartilage matrix, respectively. For
autoradiographic analysis of [35S]-sulfate
incorporation [11], radiolabeled sulfate (75 mCi)
was injected intraperitoneally 6 h before dissection
of the knee joints. After histologic processing, 6-mm
sections were prepared and mounted on
gelatin-coated slides. These were dipped in K5
emulsion (Ilford, Basildon, Essex, U.K.) and
exposed for 3–5 weeks. After this period, the slides
were developed and stained with hematoxylin and
eosin.
determination of patellar cartilage
proteoglycan synthesis
Proteoglycan synthesis was measured ex vivo
according to the method of van den Berg et al. [12].
Patellae with a standard amount of surrounding
tissue were dissected from the knee joints. Patellae
were then pulse-labeled (2 h, at 37° C) with
[35S]-sulfate. Subsequently, they were washed,
fixated in ethanol, and decalcified in formic acid.
After decalcification the entire cartilage was
stripped off, dissolved in lumasolve and
radioactivity was measured by liquid scintillation
counting. In some experiments a piece of 0.2 mm2
was punched out of the patellar cartilage for study
of the homogeneity (central part relative to
peripheral part) of growth factor effects [13].
determination of patellar cartilage
proteoglycan content
Articular cartilage PG content is reflected in
safranin O staining intensity in histological
sections. This was measured using an automated
image analysis system as described before [14].
Fast green staining was neutralized by use of a
green filter. Optical density was examined in the
non-calcified cartilage. Measurements were
corrected for chondrocyte lacunae and for
background measured in PG depleted cartilage in
which no red stain was visible any more.
rna extraction and reverse
transcriptase polymerase chain reaction
(rt-pcr)
Patellae were dissected and immediately
decalcified in 3.5% EDTA for 4 h at 4° C.
Following decalcification, the complete articular
layer was stripped from the underlying bone. The
isolated cartilage was instantly put in TRIzol
reagent (Life Technologies) for RNA extraction. In
control experiments it was shown that this
procedure did not affect the RNA isolation or
RT-PCR negatively [15]. RNA was directly
extracted from cartilage, without homogenization
of tissue. Cartilage of 10 patellae was pooled.
Before reverse transcription, the isolated RNA was
treated with DNAse 1 (Life Technologies). The
reverse transcription reaction was performed with
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moloney-murine leukemia virus (M-MLV) reverse
transcriptase (Life Technologies), using an
oligo(dT)15 primer (Eurogentec, Liege, Belgium).
Amplification of DNA was accomplished by using
Taq DNA polymerase (Life Technologies) up to a
cycle number of 40. To estimate the relative mRNA
levels, 5 ml samples were taken at increasing cycle
numbers. The PCR products were electrophorized
in 1.6% agarose gels containing ethidium bromide.
The cycle number at which the product was first
detected on the gel was taken as a measure for the
amount of specific mRNA present in the originally
isolated RNA. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA levels were used
as an internal control. This method was validated
by van Meurs et al. [15]. For determination of
growth factor effects at one time point the RNA
extracts of at least two different experiments were
analyzed by RT-PCR.
The following primers were used in the
amplification reactions. GAPDH 5'-AACTCCC-
TCAAGATTGTCAGCA-3' (upper), 5'-TCCACC-
ACCCTGTTGCTGTA-3', resulting in a 553 bp
product. Biglycan 5'-AGAAGGCCTTTAGCCC-
TCCTG-3' (upper), 5'-ACTTTGCGGATACGG-
TTGTC-3' (130 bp product). Aggrecan primers were
used as described by Grover and Roughly [16]
resulting in a 501 bp product, while decorin
primers were used according to Asundi and
Dreher [17] (400 bp). Primers detecting murine
collagen type X had the following sequences:
5'-ATACCCTTTCTGCTGCTAATGTTCTTGACC-3'
(upper), 5'-TGATATTCCTGGTGGTCCTGGCAAC-
3' (lower), resulting in a 387 bp product.
statistical analysis
Differences between experimental groups were
tested using the Student’s t-test. Differences were
considered significant if P Q 0.05.
Results
stimulation of articular cartilage pg
synthesis
Dose–response studies over a 1-week period
showed that one intra-articular injection of 200 ng
BMP-2 increased patella cartilage PG synthesis up
to three times the normal level within 2 days
[Fig. 1(a)]. Thereafter PG synthesis declined and
reached nearly basal levels at day 5 after injection.
The stimulation of PG synthesis could not be
increased beyond the level reached with 200 ng by
using a higher BMP-2 dosage (400 ng, not shown).
One injection with 20 ng BMP-2 stimulated PG
synthesis to 150% of basal level, but this
stimulation was lost within 3 days, while 2 ng was
without significant effects.
A single injection of TGF-b1 also stimulated PG
synthesis but the maximum level reached was
lower; only twice the normal synthesis rate
[Fig. 1(b)]. Moreover, this level was reached later
(after 4 days) and stimulation of PG synthesis
lasted longer as compared with BMP-2 injection.
Significant stimulation was found up to 21 days
after injection of 200 ng TGF-b (Fig. 2). Even the
20 ng TGF- b1 dose stimulated PG synthesis for at
least 7 days. Triple injections did not further
increase or prolong TGF-b1- induced stimulation of
PG synthesis (Fig. 3). In contrast, prolonged
stimulation was found after triple injections of
200 ng BMP-2. Autoradiography showed that
[35S]-sulfate incorporation was stimulated
Fig. 1. Dose-dependent stimulation of patellar cartilage
PG synthesis after a single injection of BMP-2 (a) or
TGF-b1 (b). Even the 20 ng dose of TGF-b1 still had
significant effect (P Q 0.05) at day 7. [35S]-sulfate
incorporation is expressed as percent of the vehicle-
injected control. Each value represents the mean 2 s.d.
of at least 12 animals. * Significant increase; R = 200 ng;
Q = 20 ng; W = 2 ng; – – – = vehicle.
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Fig. 2. Duration of stimulation of PG synthesis after a
single injection of 200 ng BMP-2 or TGF-b1. The effect of
BMP-2 was lost after 5 days, while TGF-b1 still had
significant effect (P Q 0.05) at day 21. [35S]-sulfate
incorporation is expressed as percent of the vehicle-in-
jected control. Each value represents the mean of at
least 12 animals. At days 14, 21, and 28 the s.d. was less
than 10%. * Significant increase; NS, not significant;
Q = BMP-2; R = TGF-b.
upregulation of mrna of different pg types
and of collagen x
Overall PG synthesis can be determined by
measurement of [35S]-sulfate incorporation, but
this reflects mainly aggrecan synthesis. To get
insight in potential effects of BMP-2 and TGF-b1
on mRNA expression of different PG types, we used
RT-PCR. Messenger RNA levels were determined
of three abundant PG types in articular cartilage;
aggrecan, biglycan and decorin. Results of
representative RT-PCR experiments showing
growth factor effects on mRNA levels of GAPDH,
aggrecan, and collagen type X are presented in
Fig. 5 (effects on biglycan and decorin are left out).
At the time point of highest PG synthesis after the
last of three BMP-2 injections, day 2, the mRNA
levels of aggrecan, biglycan, and decorin were
increased to eight, four and two times basal values,
respectively. A single injection of 200 ng BMP-2
had less, but still significant effect (not shown); at
day 2 after one BMP-2 injection, the amount of
mRNA of decorin was unchanged, while that of
aggrecan and biglycan had increased to four times
basal values. In contrast, TGF-b injections induced
upregulation of only aggrecan mRNA
(two-to-four-fold) 1 day after the last of three 200 ng
injections (not shown), and this effect was lost
already 1 day later (Fig. 5). Interestingly, the
amount of mRNA encoding for collagen type X,
indicative for chondrocyte hypertrophy, was
unchanged after TGF-b exposure, but highly
upregulated after BMP-2 injections (216 times
normal values at day 2 after third injection).
elevation of articular cartilage pg content
In order to elucidate whether the stimulation of
PG synthesis was reflected in an increase in
articular cartilage PG content, intensity of
safranin O staining in histological sections was
measured. This method, in contrast to biochemical
analysis of total cartilage, offered the opportunity
to measure especially in the uncalcified, and most
reactive, cartilage layer. BMP-2 injections
(3 · 200 ng) appeared to induce only a small,
short-lived increase of patellar cartilage PG
content (Table I), while TGF-b1 injections
(3 · 200 ng) induced prolonged enhancement of the
PG content, lasting at least 2 weeks after the third
injection. A single injection of 200 ng TGF-b1 was
almost as effective in this respect as triple
injections. Effects of TGF-b1 and TGF-b2 on
PG content appeared to be comparable (data not
shown).
homogeneously throughout the articular cartilage
both after BMP-2 and TGF-b1 injections (Fig. 4).
Using scintillation counting we confirmed that
effects on [35S]-incorporation were similar in the
central and peripheral parts of patellar cartilage
(data not shown). Effects of TGF-b1 and TGF-b2 on
proteoglycan synthesis appeared to be comparable
(data not shown).
Fig. 3. Duration of stimulation of patellar cartilage PG
synthesis after triple injections of 200 ng BMP-2 or
TGF-b1. By giving multiple injections the effect of
BMP-2 was prolonged to 14 days (P Q 0.01), while
stimulation by TGF-b1 was comparable to the effect of a
single injection. [35S]-sulfate incorporation is expressed
as percent of the vehicle-injected control. Each value
represents the mean of at least 12 animals. At days 14,
21 and 28 the s.c. was less than 10%. * Significant
increase; NS, not significant; Q = BMP-2; R = TGF-b.
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Fig. 4. Autoradiographs showing in vivo [35S]-sulfate incorporation in cartilage and chondrophytes (arrows) after
BMP-2 or TGF-b triple injections (200 ng each); hematoxylin/eosin stained frontal sections of murine knee joint. (a)
vehicle-injected control joint of (b); (b) contralateral joint of the same animal as (a) at day 4 after the last BMP-2
injection; (c) vehicle-injected control joint of (d); (d) contralateral joint of the same animal as (c) at day 4 after the
last TGF-b injection. P, patella; f, femur; c, articular cartilage; e, epiphyseal cartilage (original magnification · 100).
Induction of osteophytes
Histologic sections of knee joints demonstrated
that intra-articular injection of TGF-b and BMP-2
resulted in formation of new chondroid tissues
(Figs 6 and 7). Interestingly, these new structures
show different characteristics. BMP-2 induced
outgrowth of epiphyseal cartilage, especially in the
femur, at the level where the growth plate
approaches the articular cartilage of the patellar
groove. This chondrogenic activity appeared to be
restricted to those regions in the growth plate
adjacent to the joint space, in close contact with
the periosteum. Autoradiography (Fig. 4) showed
no effect of BMP-2 on 35S-sulfate incorporation in
the epiphyseal cartilage, indicating local
activation of only the area where the growth plate
meets the joint space. Besides in the described
regions, BMP-2 did not induce notable
development of chondroid tissue. In contrast,
TGF-b induced chondrogenesis originating from
the periosteum with apparently no need for direct
contact with epiphyseal cartilage. The
TGF-b-induced chondroid tissues developed close
to the margins of articular cartilage, at the
insertion sites of ligaments, and at the base of
menisci. They were found also on the patella,
which has no growth plate in mice, and in
superficial frontal sections of the knee, which
did not include epiphyseal cartilage (Fig. 6).
Chondro-inductive effects of TGF-b1 and BMP-2
together showed clear synergism of these two
factors in chondrogenesis (Fig. 6). At later time
points the newly formed cartilage structures lost
their PGs (no safranin O staining) and developed
into osteophytes, containing bone marrow (Fig. 7).
For this reason the newly formed cartilage
structures at early time points were termed
‘chondrophytes’. Mature osteophytes induced by
BMP-2 and TGF-b looked very much alike, except
for their localization. In search for treatments that
stimulate articular cartilage PG synthesis for at
Cycle number
GAPDH
22 24 26 28 30 22 24 26 28 30
BMP-2 Control
22 24 26 28 30 22 24 26 28 30
TGF-b 2 Control
Cycle number
Aggrecan
30 32 34 36 38 30 32 34 36 38 30 32 34 36 38 30 32 34 36 38
Cycle number
Collagen type X
28 30 32 34 36 28 30 32 34 36 28 30 32 34 36 28 30 32 34 36
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Fig. 5. Semiquantitative mRNA analysis in cartilage isolated from growth factor or vehicle injected murine joints.
Cartilage was isolated 2 days after last of three injections of 200 ng BMP-2 or TGF-b2. As a control the vehicle-injected
contralateral joints of the same animals were used. PCR products are shown after increasing numbers of cycles
from reactions with primers specific for GAPDH, aggrecan, and collagen type X. The cycle number at which the
product is first seen on the ethidium-colored gel is taken as a measure for the amount of mRNA present in the originally
isolated RNA.
least a week, without inducing chondrophytes,
dose–response studies were performed (Table II).
These studies indicated that in the triple injection
protocol chondro-induction and long-term
stimulation of PG synthesis by TGF-b or BMP-2
could not be uncoupled. TGF-b was more potent
than BMP-2 in both effects. The only protocol that
met the above mentioned requirements, was a
single injection of TGF-b. Even the 200 ng dose did
not induce chondrophytes in this protocol, and as
has been shown in figure 1B, a single injection of
all tested TGF-b dosages (2, 20, 200 ng) induced
long-term stimulation of PG synthesis.
Induction of fibrosis
TGF-b was much more potent than BMP-2 in
inducing fibrosis. Triple injections with 200 ng
TGF-b increased the amount of fibroblasts in the
synovial sublining, and also the diameter of
collateral ligaments clearly increased (Fig. 8).
BMP-2 injections had only very little effect in this
respect, but in some cases a granulous tissue
developed at the extraarticular side of collateral
ligaments. Similar structures, but larger, were
found after injections of BMP-2 + TGF-b1.
Discussion
In vitro, members of the BMP family like BMP-2,
BMP-4, BMP-7, and BMP-9 have been
demonstrated to stimulate articular chondrocyte
PG synthesis [4, 5, 18, 19], but until now no in-vivo
data were available. We reported earlier that
TGF-b1 is a potent stimulator of articular cartilage
PG synthesis and content in vivo [10]. In the
present study, we focused on the comparison of
effects of intra-articular injections of TGF-b1 and
BMP-2 on articular cartilage PG synthesis and
content in vivo.
BMP-2, like TGF-b1, appeared to be a potent
stimulator of articular cartilage PG synthesis
Fig. 6. Safranin O/fast green stained frontal sections of murine knee joint showing chondrophyte and osteophyte
development (arrows) after triple intra-articular injections of 200 ng BMP-2 or TGF-b1. (a) Normal joint, (b) superficial
section, 4 days after last BMP-2 injection, showing that remote from the growth plates no signs of chondrophyte formation
were visible, (c) deeper section, at the same time-point after the last BMP-2 injection, showing chondrophytes (stained
red) at the sites where growth plates meet the joint space, (d) 4 days after last TGF- b1 injection, chondrophyte
development more independent of growth plate (also chondrophytes on the patella) was found; also note synovial
hyperplasia, (e) 21 days after last BMP-2 injection chondrophytes had developed into osteophytes, not stained with
safranin O and containing bone marrow, (f) 21 days after the last TGF-b1 injection, osteophytes had developed that looked
very similar compared with those induced by BMP-2, (g) synergism of TGF-b1 and BMP-2 chondroinductive (and fibrotic)
actions, 4 days afer the last injection of BMP-2 + TGF-b1 (original magnification · 100).
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Table 1
Effect of intra-articular injections on patellar cartilage proteoglycan content
Injected substance days* Increase of proteoglycan content (%)†
1 · TGF-b 7 16 2 7‡
1 · TGF-b 14 17 2 8‡
3 · TGF-b 1 27 2 13‡
3 · TGF-b 4 25 2 11‡
3 · TGF-b 7 22 2 8‡
3 · TGF-b 14 15 2 6‡
3 · BMP-2 1 26 2 15‡
3 · BMP-2 2 10 2 10 Not significant
3 · BMP-2 4 9 2 7 Not significant
Days after the last injection^ in the triple injection protocol three injections "199 ng each#
were given\ at alternate days\ meaning that in this protocol day 0 after the last injection4
days from start[
$Safranin O staining intensity of histological sections measured using an automated image
analyzer[ Staining intensity of patella cartilage in vehicle injected knee joints was stated 099)[
Each experimental group consisted of at least 09 mice\ and of each joint at least four sections
were analyzed[ %P Q 9[90\ signi_cantly different from vehicle!injected joints[
in vivo. PG synthesis was stimulated homo-
geneously throughout the articular cartilage.
Interestingly, stimulation of PG synthesis by
BMP-2 and TGF-b1 showed different kinetics.
Stimulation of PG synthesis by BMP-2 was much
earlier and stronger, but also of shorter duration
than stimulation by TGF-b. The retarded
stimulation of PG synthesis by TGF-b could
indicate that the first event is production of a
second mediator, or a change in chondrocyte
phenotype. An explanation of the prolonged
stimulation of PG synthesis seen after TGF-b
injection could be TGF-b autoinduction [20, 21],
but also changes in mechanical forces on articular
cartilage due to TGF-b-induced fibrosis and
chondrophyte development could be responsible.
In contrast to the long-term disturbance of overall
PG synthesis, TGF-b induced only slight, transient
changes in mRNA levels of aggrecan and did not
change message of the two small PGs. Thus, on the
mRNA level we found no indication of changes in
the balance between large and small PGs during
TGF-b-induced PG overproduction. Substantial
shifts in favour of the smaller PG classes were
described in the literature, but this always
concerned TGF-b effects on other cell types and in
vitro [22–24]. Reported TGF-b effects on human
articular chondrocyte PG gene expression in vitro
[25, 26] are much smaller (biglycan · 2,
decorin · 0.5, aggrecan · 4). This is more in line
with our findings in murine articular cartilage in
vivo, especially if we take into account that with
RT-PCR it is not easy to pick up a shift of one cycle.
BMP-2 effects on PG message were larger than
those of TGF-b, and resulted in a shift in favor of
aggrecan. Because of the short duration of BMP-2
effects on PG synthesis, and content, we suppose
this will not have too much influence on the
composition of the cartilage extracellular matrix.
BMP-2 also strongly stimulated collagen type X
mRNA expression. As type X collagen is
synthesized primarily by hypertrophic
chondrocytes [27, 28], this finding indicates that
BMP-2 may be involved in induction of the
hypertrophic phenotype.
Stimulation of PG synthesis was reflected in
increased PG content after TGF-b, but not after
BMP-2 injections. This might be caused by the
short duration of BMP-2 induced stimulation of
PG synthesis, but also TGF-b could promote PG
binding to matrix or chondrocytes by inducing HA
production [29] or by stimulation of integrin
expression on chondrocytes [30]. Moreover, TGF-b
might enhance PG content by suppressing PG
degradation [1, 25, 31]. However, also members of
the BMP family seem to have, at least in vitro, the
potential to inhibit PG breakdown [19, 32].
Apart from its strong effects on cartilage PG
metabolism, TGF-b was also much more potent
than BMP-2 in induction of fibrosis. This was seen
in the synovium, but also ligaments increased in
diameter after TGF-b injections. The difference in
fibrogenic properties of BMP-2 and TGF-b1 we
showed is in line with a study that compared
BMP-7 and TGF-b1 effects on fibroblast
proliferation and matrix synthesis [33]. Another
periarticular change we observed was the
induction of chondrophytes, which eventually
developed into osteophytes. Intra-articular
injections of BMP-2 resulted in the formation of
new chondroid tissue, especially in the
femoropatellar area. The ability of BMP-2 to
induce the formation of new cartilage and bone has
been demonstrated before, using the rat ectopic
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Fig. 7. Safranin O/fast green stained frontal sections of
murine knee joint illustrating the transformation of
TGF-b2-induced chondrophytes into osteophytes. (a)
chondrophytes seen at the margins of patellar cartilage
at day 5 after the last of three injections of 200 ng
TGF-b2, (b) osteophytes found at the same sites one
month after the last injection. CP, chondrophyte; OP,
osteophyte; C, cartilage; BM, bone marrow (original
magnification · 400)
intra-articular injections of TGF-b1 induced
chondrophytes which develop into osteophytes
[10]. Interestingly, the BMP-2-induced
chondrophytes are quite different as compared
with those induced by TGF-b. The BMP-2-induced
chondrophytes are always growing in close contact
with the area where growth plates meet the joint
space, while those induced by TGF-b seem to
develop more independently of these sites. Also the
observation that the most pronounced
TGF-b-induced chondrophyte development was on
the patella (lacking a growth plate), while after
BMP-2 injections chondrophytes were rarely seen
on the patella, but predominantly on the femur,
points in this direction. Autoradiography did not
show BMP-induced activation, at the level of
proteoglycan synthesis, of the growth plates
themselves. This indicates that the chondroid
tissue had originated from the periosteum, or from
the surface of the growth plate adjacent to the
joint space. Several studies performed in other
systems also show that BMP-2 and TGF-b act
different in inducing cartilage and bone
production [36–38]. This could indicate that BMP-2
and TGF-b may act by different mechanisms, or
that because of variable receptor expression they
activate different cell populations. Additional
evidence for the existence of differential activation
pathways is the synergism in chondrophyte
induction that we found after injecting BMP-2 and
TGF-b into the same joint. Because of the
characteristic appearance and localization of early
BMP-2-induced chondrophytes, we can speculate
about the relative contribution of BMP and TGF-b
in osteophyte induction during natural processes
in mice. From the appearance of arthritis-induced
chondrophytes we conclude that there is no
physiological role for BMP in this process.
Moreover, the localization of osteophytes in
naturally occurring and experimental
osteoarthritis in mice also is more similar to that
induced by TGF-b than BMP-2 injections, but we
do not know what early chondrophytes in these
conditions look like.
bone formation assay [7, 34]. Other members of the
BMP family, like BMP-3, BMP-4, BMP-5, and
BMP-7 are also able to induce new cartilage and
bone in vivo [7, 34, 35]. As we demonstrated before,
Table 2
Correlation between long-term stimulation of PG synthesis and induction of
chondrophytes by BMP-2 and TGF-b
Injected substance Chondrophytes Stimulation of PG synthesis ( q 1 week)
1 · 200 ng TGF-b - +
3 · 200 ng TGF-b + +
3 · 20 ng TGF-b + +
3 · 2 ng TGF-b - -
1 · 200 ng BMP-2 - -
3 · 200 ng BMP-2 + +
3 · 20 ng BMP-2 - -
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Fig. 8. Safranin O/fast green stained frontal sections of murine knee joint showing effects on collateral ligaments
induced by triple intra-articular injections of 200 ng BMP-2 or TGF-b1. (a) Normal joint; (b) 4 days after the last BMP-2
injection there is no fibrosis of ligaments, but in some cases a new granulous structure, hardly stained, has developed
at the extra-articular side of the ligament, and a chondrophyte is present at the end of the growth plate (arrows); (c)
4 days after the last TGF-b1 injection the collateral ligaments are thicker and in some cases they stain red instead
of green, indicating enhanced PG content, presumably a sign of chondrogenesis; (d) 4 days after the last coinjection
of TGF-b1 and BMP-2, with large chondrophyte at the extra-articular side of the ligament (arrows). F, femur; T, tibia
CL, collateral ligament (original magnification · 100).
A single injection of 200 ng TGF-b appeared to
induce long-term enhancement of articular
cartilage PG synthesis and content, with only
moderate fibrosis and no chondrophytes. For
induction of chondrophyte formation repeated
injections were needed. Three injections of a 10
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times lower dose still induced chondrophyte
formation. BMP-2 was less potent also in this
respect, because three injections of 20 ng BMP-2
appeared to have no chondroinductive capacity. In
the triple injection protocol we did not succeed
in finding dosages that had significant effects
on cartilage PG metabolism, without inducing
chondrophytes. There is evidence that
periosteum of rodents is more responsive to
chondrophyte-inducing factors as compared with
primates [39, 40], indicating that BMP- or
TGF-b-induced formation of chondrophytes and
osteophytes might be less of a problem in humans.
In summary, this study demonstrates that local
administration of BMP-2 or TGF-b into normal
joints stimulates articular cartilage PG synthesis.
TGF-b has the highest impact, because of its
long-lasting enhancement of both PG synthesis
and PG content, and seems to be the most
promising factor for replenishment of PG in
depleted cartilage in pathological conditions.
However, formation of chondrophytes might limit
the therapeutic applications of TGF-b and BMP-2.
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